BioSpace News Archive

The shareholders of Calliditas Therapeutics AB, Reg. No. 556659-9766, with registered office in Stockholm, are summoned to the annual general meeting on Thursday 19 May 2022.

West Pharmaceutical Services, Inc. announced that it will release first-quarter 2022 financial results before the market opens on Thursday, April 28, 2022, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

Osivax, a biopharmaceutical company developing vaccines to protect against highly mutating infectious diseases, announced the appointment of Dr. Michael Watson to its Board of Directors.

Alzheon, Inc. announced that it has completed an oversubscribed $50 million Series D round from private and institutional investors.

Merck has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration for the prevention of invasive pneumococcal disease and pneumococcal pneumonia caused by Streptococcus pneumoniae serotypes 3, 6A/C, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B/C, 16F, 17F, 19A, 20, 22F, 23A, 23B, 24F, 31, 33F, 35B in adults 18 years of age and older.

Amryt today announces that its unaudited financial results for the first quarter 2022 will be released on Wednesday, May 4, 2022at 0700 ET/1200 BST.

The rising prevalence of diseases such as rheumatoid arthritis will add boost to the growth of the global glucosamine market during the forecast period, 2020 to 2030.

The increasing cases of cancer are prognosticated to help boost the global advanced glycation end products market growth during the forecast period 2020 to 2030.

Mycoplasmas, a group of self-replicating bacteria, are viewed as the most persistent microbial contaminant of cultured cells.

DUBAI, United Arab Emirates, Increase In awareness regarding advanced skincare products and rising prevalence of chronic diseases are expected to drive skincare market.